Today’s Research on CELG, ARNA, INCY, SPPI, and GERN
May 21, 2013
from ACCESSWIRE
EnteroMedics (NASDAQ: ETRM) is a company that focuses on gastrointestinal and metabolic diseases with its flagship product VBLOC®, which is a first-in-class weight loss treatment that prevents obesity... Read More
from Bio-Wire.Com
Art Pappas Elected to NVCA Board of Directors
May 15, 2013
from PR Newswire
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
Why Does Arena's Obesity Drug Have Abuse Potential?
May 11, 2013
from Forbes Real Time
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
from PR Newswire
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals
May 10, 2013
category
OTCBB:ELTP
,
NASDAQ:ARNA
The New Diet Pill Players: Arena and Vivus
May 08, 2013
from YCharts
Over the past 24 hours, two developments finally occurred to suggest overweight consumers will soon have an expanding choice of prescription diet pill options. First, Arena Pharmaceuticals disclosed... Read More
from Forbes Real Time
category
companyNews
Bullish bets were unusually popular on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) yesterday, with call volume on the drug stock rising to more than three times the expected level...( Read More ) Read More
category
ARNA
Record Day For Dow, S&P 500
May 07, 2013
The Dow closed above the 15,000 mark for the first time by climbing 87 points to 15,056. Nasdaq rose 3 points to 3396. Read More
category
Market News
UPDATE: Arena Pharma Issues Update on Upcoming US Launch of BELVIQ, to Get $65M Milestone Payment from Eisai
May 07, 2013
Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management
May 07, 2013
from PR Newswire
Belviq Is Not the Next Fen-Phen … Probably
May 07, 2013
category
Hot Stocks
,
NASDAQ:ARNA
Arena & VIVUS Weaken On Poor Obesity Drug Prospects In Europe Responding to news that the company would withdraw its MAA (Marketing Authorization Application) for Belviq (lorcaserin) from the EMA... Read More
from Bio-Wire.Com
Arena Pharmaceuticals (ARNA) - Market Review
May 07, 2013
from AVAFIN
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
Bio-Wire Weekly: April 29 – May 3rd, 2013 To get this email earlier, sign up for our email list The Newsmakers: 1.) Auxilium Pharmaceuticals (NASDAQ: AUXL) Auxilium Pharma was down about 8% in the last... Read More
from Bio-Wire.Com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here